Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma
Clinical trial NCT03026517 · COMPLETED
Trial details
- NCT number
- NCT03026517
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2025-01-21
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.